Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MET 097

Next Previous
X
Search
Drug Profile

MET 097

Alternative Names: GLP-1 receptor agonist - Metsera; MET-097; MET-097i

Latest Information Update: 10 Jan 2025

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Metsera
  • Class Glucagon-like peptides; Obesity therapies; Peptides
  • Mechanism of Action Glucagon-like peptide-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Obesity
  • Phase I/II Metabolic disorders

Most Recent Events

  • 10 Jan 2025 Metsera plans additional trials in Obesity and Type 2 diabetes in 2025
  • 08 Jan 2025 Efficacy, adverse events and pharmacokinetics data from a phase IIb trial in Obesity released by Metsera
  • 13 Nov 2024 Clinical trials in Obesity (Combination therapy) (SC) before November 2024

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top